Daigou and direct-selling clampdown in China 'growing pains', but market will still thrive: HPA

By Cheryl Tay

05-May-2019 - Last updated on 06-May-2019 at 00:35 GMT

The recent slew of crackdowns, regulatory reviews and stricter rules for China's health food and supplement industry are 'growing pains' the industry must overcome, as regulators double down on efforts to promote safety and collect taxes.

Read the full story here.

Top 10 stories (April 2019)

Nu Skin investigating death of Chinese woman who relied on supplements and refused medical treatment

Kiwi nootropic firm aiming to become 'world's most iconic brain health brand'

Probiotics regulations under review in China as regulator SAMR 'plays catch-up'

Freedom Foods expects lactoferrin production to meet rising domestic and Asia demand

China health claims concerns: Huge industry uncertainty as regulator embarks on regulations review

Chapati for weight loss? OptiBiotix outlines Indian plans for SlimBiome after FSSAI approval

New number one: Australia takes top spot from US for supplements and health foods imported into China

Asahi JV launches new mother and baby formula range to drive growth in Vietnam

Daigou and direct-selling clampdown in China 'growing pains', but market will still thrive: HPA

Chinese mothers buying less infant formula but more supplements via cross-border e-commerce: Tmall Global

Related news

Follow us

Products

View more

Webinars

Upcoming editorial webinars

14 May 2024 Tue Webinar Healthy Ageing APAC

On-demand webinars

Nutra Champions Podcast

Nutra Champions Podcast

Headlines